Experience a supportive community that understands your struggles
When Semazic is added to existing therapy of sulfonylurea or insulin, a reduction in the dose of sulfonylurea or insulin should be considered to reduce the risk of hypoglycemia
Gastrointestinal Adverse Reactions In the pool of placebo-controlled trials, gastrointestinal adverse reactions occurred more frequently among patients receiving OZEMPIC than placebo (placebo 15.3%, OZEMPIC 0.5 mg 32.7%, OZEMPIC 1 mg 36.4%)
Method Database We used TriNetX, a global federated health research network providing analytics to access and analyze de-identified and aggregated electronic medical records (diagnoses, procedures, medications, laboratory values, genomic information) from approximately 105.3 million patients in 61 large healthcare organizations
26 -- now
It could also reduce markers of liver inflammatory activities and support reduction in body weight, fat mass, and hip circumference, all while being safe and well-tolerated
